ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
+5.76%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
AUM
$238M
AUM Growth
+$238M
Cap. Flow
-$12.3M
Cap. Flow %
-5.17%
Top 10 Hldgs %
92.15%
Holding
15
New
2
Increased
5
Reduced
6
Closed
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$40.3M 14.52%
1,218,515
+20,000
+2% +$661K
BPMC
2
DELISTED
Blueprint Medicines
BPMC
$34.5M 12.45%
524,268
-192,271
-27% -$12.7M
MRUS icon
3
Merus
MRUS
$4.98B
$30.2M 10.88%
1,507,109
+30,000
+2% +$601K
ARVN icon
4
Arvinas
ARVN
$568M
$29.9M 10.77%
671,745
-100,000
-13% -$4.45M
RGNX icon
5
Regenxbio
RGNX
$451M
$25.6M 9.22%
967,684
-200,000
-17% -$5.29M
QURE icon
6
uniQure
QURE
$896M
$15.8M 5.69%
841,471
-130,019
-13% -$2.44M
AMYT
7
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$13.8M 4.99%
1,998,993
+132,341
+7% +$916K
SLN
8
Silence Therapeutics
SLN
$227M
$12.7M 4.57%
+1,263,125
New +$12.7M
ARGX icon
9
argenx
ARGX
$43.6B
$8.47M 3.05%
24,000
GMAB icon
10
Genmab
GMAB
$15.3B
$7.87M 2.84%
244,848
+30,000
+14% +$964K
KYMR icon
11
Kymera Therapeutics
KYMR
$2.95B
$7.19M 2.59%
+330,246
New +$7.19M
SPRO icon
12
Spero Therapeutics
SPRO
$116M
$6.81M 2.45%
3,403,210
-1,918,021
-36% -$3.84M
PVLA
13
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$4.64M 1.67%
4,036,280
+300,000
+8% +$345K
FDMT icon
14
4D Molecular Therapeutics
FDMT
$288M
$29K 0.01%
3,573
-858,034
-100% -$6.96M
XBI icon
15
SPDR S&P Biotech ETF
XBI
$5.07B
0